Arena pharmaceuticals, inc. (ARNA)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating Activities:
Net income (loss)

-322,786

397,555

554,577

593,128

622,698

-29,399

-112,065

-110,415

-102,198

-92,732

-40,463

-20,278

-23,845

-22,896

-91,669

-105,608

-105,232

-107,979

-109,581

-93,835

-59,548

-60,508

-51,906

-58,434

-25,814

-19,435

-17,256

-15,577

-77,776

-85,477

-87,879

-95,094

-95,903

-109,224

0

0

0

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
(Income) loss from discontinued operations

-

-

-

-

-

-830

-515

2,091

2,238

3,122

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

3,419

3,233

3,245

3,412

3,574

3,759

3,907

3,990

4,117

4,278

1,223

2,475

3,748

4,994

5,034

5,190

5,361

5,430

9,622

9,403

9,088

8,655

8,404

8,057

7,775

7,733

7,758

8,208

8,600

9,055

9,493

9,715

9,972

10,127

0

0

0

Deferred income taxes

-

110,333

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of intangibles

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

278

-

259

307

352

506

558

564

551

469

479

536

614

691

695

724

737

997

0

0

0

Share-based compensation

55,237

53,047

45,611

37,432

28,534

19,543

15,826

12,537

10,117

7,855

7,572

7,876

10,037

11,075

11,578

13,245

13,088

14,112

15,363

14,913

14,141

13,509

12,423

11,344

10,440

9,024

7,901

6,934

5,450

5,072

4,515

3,955

3,825

3,748

0

0

0

Gain from valuation of derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

474

1,403

3,144

2,979

4,418

3,538

5,045

6,181

10,150

10,562

11,721

-7,191

-13,425

-14,226

-19,718

-2,767

47

0

0

0

Amortization of prepaid financing costs

90

90

94

100

104

110

117

123

130

136

136

136

136

136

136

136

136

136

136

136

136

136

136

136

136

136

136

136

241

292

312

329

240

438

0

0

0

Amortization of original issue discounts, net of premiums, on available-for-sale investments

4,745

5,628

5,793

3,930

1,639

664

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,338

-6,338

-6,338

-1,670

-10,514

0

0

0

Loss (gain) on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,270

-798

-846

-872

-1,007

-1,007

-219

-217

-172

-242

4

-4

-49

0

0

0

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

-2,927

-3,432

370

-337

1,418

2,760

-136

1,022

797

-10,787

-12,527

1,937

-1,066

12,246

12,457

-2,858

-8,326

-781

756

-2,808

11,139

-6,407

-9,136

5,690

-448

4,473

11,152

-19,051

894

5,260

-911

18,708

-2,001

-2,878

0

0

0

Inventory

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-3,028

-

-1,899

-1,348

230

-870

2,334

4,511

3,862

6,065

6,618

7,100

7,175

5,875

0

0

0

-

-

-

-

Prepaid expenses and other assets

9,782

8,133

10,698

14,735

11,711

2,929

1,172

-871

-1,820

-585

-1,685

-2,215

-2,906

-2,416

789

2,129

2,010

641

-1,413

-1,111

-2,291

772

2,653

1,444

2,538

65

-1,015

320

1,109

1,524

2,032

673

124

-539

0

0

0

Payables and accrued liabilities

10,151

12,347

14,061

9,340

15,389

10,871

6,385

7,775

1,569

1,803

-8,977

-8,729

172

2,410

27,999

24,318

3,653

-2,092

-11,451

-3,084

8,142

13,240

5,169

13,424

18,769

19,572

18,427

4,352

2,103

276

-323

-1,711

-3,370

-1,117

0

0

0

Deferred revenues

-

-

-

-

-

-2,061

-2,040

-2,857

-3,741

-4,401

-67,356

-67,062

-71,170

-69,078

-14,082

-19,220

-12,305

-4,647

-2,260

-9,360

-16,334

-29,764

40,317

69,032

72,048

75,880

28,046

11,429

17,717

17,849

1,849

1,738

-3,289

-3,395

0

0

0

Deferred rent

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

0

-

-

-

117

122

127

132

132

125

118

16

-31

-103

-178

-158

-190

-187

0

0

0

Other long-term liabilities

-

-

-

-

-

-

-

-

-

-577

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) operating activities - continuing operations

-

-

-

-

-

-131,879

-105,383

-93,837

-80,636

-63,792

-74,392

-74,883

-66,049

-71,293

0

0

0

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities - discontinued operations

-

-

-

-

-

-333

709

1,877

471

-2,850

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) operating activities

-263,001

568,694

596,436

617,829

635,218

-132,212

-104,674

-91,960

-80,165

-66,642

0

0

0

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

0

-

-50,730

-68,753

-76,103

-78,257

0

0

0

Investing Activities:
Purchases of available-for-sale investments

1,402,489

1,469,220

1,587,604

1,248,793

588,587

364,539

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale and maturity of available-for-sale investments

1,122,240

976,093

644,972

323,448

161,647

110,564

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

4,256

4,819

3,057

2,098

1,462

692

655

616

425

113

196

462

580

814

-9,037

-273

297

1,119

13,261

6,255

7,505

8,905

11,008

10,433

10,367

9,164

5,342

4,291

2,769

1,777

1,307

1,003

803

619

0

0

0

Proceeds from sale of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

954

786

2,393

2,367

2,232

2,232

0

2

47

47

75

105

60

0

0

0

-

-

-

-

-

-

-

-

Other non-current assets

-

-

-

-

-

11

-1

-3

5

5

0

0

0

-

-

-

-

-

-

-

-

-209

-181

-391

-700

-439

-362

205

527

425

428

71

39

86

0

0

0

Net cash used in investing activities - continuing operations

-

-

-

-

-

-254,678

-54,221

-91,422

-113,134

-112,350

761

-329

-417

-514

0

0

0

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities - discontinued operations

-

-

-

-

-

3,405

3,334

3,334

2,890

-40

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

-283,508

-496,949

-944,704

-926,459

-427,996

-251,273

0

0

0

-

-

-

0

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

0

-

-1,711

-1,041

-809

-672

0

0

0

Principal payments on lease financing obligations

3,409

3,282

3,384

3,594

3,800

4,000

3,962

3,810

3,662

3,518

3,378

3,242

3,108

2,979

2,852

2,729

2,609

2,492

2,379

2,268

2,161

2,057

1,955

1,855

1,758

1,664

1,573

1,483

1,397

1,313

1,231

1,151

1,073

998

0

0

0

Proceeds from issuance of common stock, net

12,974

13,147

13,240

10,108

7,139

389,031

388,955

554,318

628,794

248,805

248,411

81,636

5,510

370

982

1,195

1,776

103,628

103,267

103,630

104,277

5,225

5,522

5,562

5,792

3,315

3,246

25,617

110,385

151,218

150,734

127,761

41,598

17,977

0

0

0

Proceeds from issuance of preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16,462

16,463

16,463

16,375

17,662

0

0

0

Net cash provided by (used in) financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

9,565

9,865

9,856

6,514

3,339

385,031

384,993

550,508

625,132

245,287

0

0

0

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

0

-

139,991

117,098

44,270

-14,158

0

0

0

Effect of exchange rate changes on cash

-6

-10

-4

95

39

654

493

-6

1,889

1,870

367

1,155

-1,316

-294

604

-1,739

-746

-1,897

-1,207

-82

-1,158

-1,343

-1,243

592

642

1

-94

-525

-383

571

341

-1,087

973

50

0

0

0

Net increase (decrease) in cash, cash equivalents and restricted cash

-536,950

81,600

-338,416

-302,021

210,600

2,200

229,925

370,454

436,612

68,125

177,772

9,440

-59,341

-64,809

-79,651

-94,715

-101,448

-7,025

-7,048

15,903

37,709

-58,669

7,625

21,893

67,022

65,787

14,929

35,094

48,057

98,459

87,891

46,217

-31,669

-93,037

0

0

0